![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Alibhai Shabbir M. H. O'Neill Meagan E.
Publisher: Blackwell Publishing
E-ISSN: 1097-0142|121|20|3574-3576
ISSN: 0008-543X
Source: Cancer, Vol.121, Iss.20, 2015-10, pp. : 3574-3576
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Ording Anne G. Horváth-Puhó Erzsébet Lash Timothy L. Ehrenstein Vera Borre Michael Vyberg Mogens Sørensen Henrik T.
Cancer, Vol. 121, Iss. 20, 2015-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bevacizumab: increased risk of venous thromboembolism
Reactions Weekly, Vol. 1, Iss. 1230, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bevacizumab: increased risk of venous thromboembolism
Inpharma, Vol. 1, Iss. 1666, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Oral HRT doubles venous thromboembolism risk
Inpharma, Vol. 1, Iss. 1641, 2008-01 ,pp. :